Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada.
J Clin Microbiol. 2013 Feb;51(2):466-71. doi: 10.1128/JCM.02329-12. Epub 2012 Nov 21.
This study assesses the detection performance of CHROMagar STEC medium relative to a reference cytotoxin assay and describes the current relative prevalence of O157 and non-O157 Shiga toxin-producing Escherichia coli (STEC) serotypes within the province of Manitoba, Canada. Over a 10-month period, 205 nonfrozen routine stool submissions to Cadham Provincial Laboratory (CPL) were used to assess the performance of CHROMagar STEC. Of the 205 stools, 14 were identified as true positives by a cytotoxin assay, with resultant CHROMagar STEC sensitivity, specificity, and positive predictive and negative predictive values of 85.7%, 95.8%, 60.0%, and 98.9%, respectively. Using a separate panel of 111 STEC strains, CHROMagar STEC was shown to support the growth of 96 (86.5%) isolates. To assess relative prevalence, attempts were made to isolate by any means all STEC strains identified at CPL over a 17-month period. Of 49 isolates (representing 86.0% of all STEC infections detected), only 28.6% were O157 STEC strains. Of the 35 non-O157 STEC strains, 29 were subjected to further molecular analysis. In contrast to earlier results from our area, carriage of stx(2) appears to have increased. Overall, although CHROMagar STEC is not recommended as a primary screen, our results indicate that it is an effective supplemental medium for the isolation of probable STEC strains. Increased isolation of these serotypes is warranted to better understand their prevalence, clinical characteristics, and epidemiology and aid in the development or enhancement of food safety control programs targeting all STEC serotypes.
本研究评估了 CHROMagar STEC 培养基相对于参考细胞毒素检测的检测性能,并描述了加拿大马尼托巴省目前 O157 和非 O157 志贺毒素产生大肠杆菌 (STEC) 血清型的相对流行率。在 10 个月的时间里,使用 Cadham 省级实验室(CPL)的 205 份非冷冻常规粪便送检样本评估 CHROMagar STEC 的性能。在 205 份粪便中,有 14 份通过细胞毒素检测被确认为真正的阳性,CHROMagar STEC 的灵敏度、特异性、阳性预测值和阴性预测值分别为 85.7%、95.8%、60.0%和 98.9%。使用 111 株 STEC 菌株的单独面板,CHROMagar STEC 被证明支持 96(86.5%)株的生长。为了评估相对流行率,尝试通过任何手段分离 CPL 在 17 个月期间发现的所有 STEC 菌株。在 49 株分离株(代表所有检测到的 STEC 感染的 86.0%)中,只有 28.6%是 O157 STEC 菌株。在 35 株非 O157 STEC 菌株中,有 29 株进行了进一步的分子分析。与我们地区早期的结果相比,stx(2)的携带似乎有所增加。总的来说,尽管 CHROMagar STEC 不建议作为首选筛查方法,但我们的结果表明它是一种有效的辅助培养基,可用于分离可能的 STEC 菌株。需要增加这些血清型的分离,以更好地了解它们的流行率、临床特征和流行病学,并有助于制定或加强针对所有 STEC 血清型的食品安全控制计划。